Kiniksa Pharmaceuticals International, plc — Form 4
Filed November 3, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 59/100
What the filing says
CHAIRMAN & CEO Patel Sanj K (KNSA) sold 634K shares (~$37.4M) on the open market (81% of holdings). Large sale — ~81% of holdings.
Why this rating
Large sale — ~81% of holdings.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.